PMD Alliance is a 501c3 nonprofit organization dedicated to educating, empowering, and connecting people with movement disorders, their families, and the healthcare providers and community members who care for them.
Advanced Therapeutics in Movement & Related Disorders® Congress (ATMRD)
Friday, June 27 to Monday, June 30, 2025
Gaylord National Resort & Convention Center
Washington, DC - National Harbor
About ATMRD:
Movement disorder clinicians from around the world—join us in Washington D.C. to experience hands-on training with the latest therapies, receive cutting-edge education in clinical research, and leave ready to apply new techniques in your practice.
What makes ATMRD unique:
Other neurological conferences stop at diagnosis, but ATMRD centers patient quality-of-life, with four days of in-depth insights designed to immediately enhance your care, renew your passion, and forge interdisciplinary relationships that will support your work for years to come.
Decades of symptom management for your patients. Lifelong collaborations for you. Learn more and register here: www.atmrd.org.
Gender Disparities in Mood and Quality of Life of Parkinson Disease After DBS: Molly Abbott, BM BCh
July 10th 2025The neuropsychiatry researcher at King's College London highlighted significant gender differences in anxiety, depression, quality of life, and social support among patients with PD undergoing deep brain stimulation. [WATCH TIME: 5 minutes]
Understanding the Phenomenology and Impact of Psychosis in Parkinson Disease: William Ondo, MD
June 30th 2025The director of the Movement Disorders Clinic at Houston Methodist Hospital discussed the distinct features, progression, and clinical implications of psychosis in Parkinson disease. [WATCH TIME: 4 minutes]
Incorporating Palliative Care Principles into Movement Disorder Management: Jennifer Corcoran, MD
June 30th 2025The movement disorder neurologist at University of Rochester Medical Center outlined a 5-pillar model that emphasized holistic care, patient-centered communication, and proactive support in movement disorders. [WATCH TIME: 5 minutes]
Improving the Management of Parkinson Through Psychological Interventions: Marcia Pasqualini, PhD
June 30th 2025The professor of psychology at Avila University discussed how cognitive behavioral therapy and social support can help to improve quality of life for individuals with Parkinson disease. [WATCH TIME: 4 minutes]
Reviewing Evidence-Based Rehabilitation for Voice and Movement in Parkinson Disease Care
June 27th 2025Cynthia Fox, PhD, CCC-SLP, CEO and co-founder of LSVT Global, discussed the evolution of rehabilitative therapies in PD and stressed early referrals for speech, physical, and occupational therapy.
Patient and Clinician Perspectives on Empathy in Parkinson Disease Care: Daniel Irizarry, MD
June 27th 2025The medical advisor at Tactical Medical Solutions shared insights from both clinical and personal perspectives on the importance of empathy and active listening in managing Parkinson disease. [WATCH TIME: 3 minutes]
Advancing Neurology Through Compassion and Innovation: Insights from Dr. Hubble
February 3rd 2025Jean Hubble, MD, a retired movement disorder specialist and consultant to the PMD Alliance, shares her reflections on National Women Physicians Day, the unique contributions of women in neurology, and the pathways to fostering future leaders in movement disorders care.
The Importance of Open Communication in Patient Care: Kelly Papesh, DNP, APRN, FNP-BC
July 7th 2024The executive director of the Association of Movement Disorder Advanced Practice Providers discussed how effective patient care in movement disorders can lead to better management and treatment outcomes. [WATCH TIME: 4 minutes]
NeurologyLive® Clinician of the Month Spotlight: Kelly Papesh, DNP, APRN, FNP-BC
April 27th 2024As part of our monthly clinician spotlight, NeurologyLive® highlighted movement disorder expert Kelly Papesh, DNP, APRN, FNP-BC, executive director of the Association of Movement Disorder Advanced Practice Providers.
A Clinical Preview of 2024 for Movement Disorders: Kelly Papesh, DNP, APRN, FNP-BC
January 15th 2024The clinical director of Parkinson & Movement Disorder Alliance shared her thoughts on potential therapies to increase management care options for patients with Parkinson disease. [WATCH TIME: 5 minutes]
Botulinumtoxins in the Management of Movement Disorders: Laxman Bahroo, DO
August 8th 2023The professor of neurology and residency program director at MedStar Georgetown University Hospital spoke to the evolution of the utility of botulinumtoxins in the treatment of patients with Parkinson and other movement disorders. [WATCH TIME: 4 minutes]
Patient-Centric, Knowledge-Driven: Advanced Therapeutics in Movement and Related Disorders™ Congress
July 14th 2023Clinicians must be armed with fact-based information on all treatment options especially newer medications and technologies—good clinical care must be both patient-centric and knowledge-driven.
Filling a Therapeutic Need in Parkinson Disease: Flexibility With IPX203
June 13th 2023Robert A. Hauser, MD, MBA, director of the Parkinson’s and Movement Disorders Center at the University of South Florida, provided insight on the therapeutic potential of IPX203, and why it adds flexibility to the treatment of Parkinson disease.
Extended-Release Amantadine Offers More Predictable Good ON Time for Those With Parkinson Disease
June 12th 2023Pooled results of a post hoc analysis from phase 3 studies of amantadine (Gocovri; Supernus) suggest that the therapy offers increased good ON time, and in intervals that are more predictable for patients, compared with placebo.
Increasing Utilization of Deep Brain Stimulation in Clinical Practice: Fiona Gupta, MD
June 12th 2023The assistant professor of neurology and director of the Movement Disorders Outreach Program at Mount Sinai Medical Center shed some light on the use of DBS in the clinic and how it has evolved as a therapeutic option for patients with Parkinson disease. [WATCH TIME: 2 minutes]